Review and Perspectives on Bifidobacterium lactis for Infants’ and Children’s Health
-
Published:2023-10-05
Issue:10
Volume:11
Page:2501
-
ISSN:2076-2607
-
Container-title:Microorganisms
-
language:en
-
Short-container-title:Microorganisms
Author:
Tremblay Annie1, Bronner Stéphane1, Binda Sylvie12ORCID
Affiliation:
1. Rosell Institute for Microbiome and Probiotics, 6100 Royalmount Avenue, Montreal, QC H4P 2R2, Canada 2. Lallemand Health Solutions, 19 Rue des Briquetiers, BP 59, 31702 Toulouse, France
Abstract
The influence of microbiota dysbiosis in early life is increasingly recognized as a risk factor for the development of several chronic diseases later in life, including an increased risk of asthma, eczema, allergies, obesity, and neurodevelopmental disorders. The question whether the potential lifelong consequences of early life dysbiosis could be mitigated by restoring microbiota composition remains unresolved. However, the current evidence base suggests that protecting the normal development of the microbiome during this critical developmental window could represent a valuable public health strategy to curb the incidence of chronic and lifestyle-related diseases. Probiotic Bifidobacteria are likely candidates for this purpose in newborns and infants considering the natural dominance of this genus on microbiota composition in early life. Moreover, the most frequently reported microbiota composition alteration in association with newborn and infant diseases, including necrotizing enterocolitis and diarrhea, is a reduction in Bifidobacteria levels. Several studies have assessed the effects of B. animalis subsp. lactis strains in newborns and infants, but recent expert opinions recommend analyzing their efficacy at the strain-specific level. Hence, using the B94 strain as an example, this review summarizes the clinical evidence available in infants and children in various indications, discussing the safety and potential modes of actions while providing perspectives on the concept of “non-infant-type” probiotics for infants’ health.
Subject
Virology,Microbiology (medical),Microbiology
Reference73 articles.
1. Stinson, L.F., Boyce, M.C., Payne, M.S., and Keelan, J.A. (2019). The Not-so-Sterile Womb: Evidence That the Human Fetus Is Exposed to Bacteria Prior to Birth. Front. Microbiol., 10. 2. Miko, E., Csaszar, A., Bodis, J., and Kovacs, K. (2022). The Maternal-Fetal Gut Microbiota Axis: Physiological Changes, Dietary Influence, and Modulation Possibilities. Life, 12. 3. Gschwind, R., Fournier, T., Kennedy, S., Tsatsaris, V., Cordier, A.G., Barbut, F., Butel, M.J., and Wydau-Dematteis, S. (2020). Evidence for contamination as the origin for bacteria found in human placenta rather than a microbiota. PLoS ONE, 15. 4. Senn, V., Bassler, D., Choudhury, R., Scholkmann, F., Righini-Grunder, F., Vuille-dit-Bille, R.N., and Restin, T. (2020). Microbial Colonization From the Fetus to Early Childhood—A Comprehensive Review. Front. Cell. Infect. Microbiol., 10. 5. The infant microbiome development: Mom matters;Mueller;Trends Mol. Med.,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|